A genetic test identifying predisposition genes for chronic diseases including metabolic and degenerative conditions. This test assesses genetic risk factors for conditions like diabetes, hypertension, and obesity.
Manufactured by
Shenzhen HaploX Biotechnology Co., Ltd.
China
HaploX Biotechnology specializes in tumor liquid biopsy and genetic big data technologies. The company operates CAP/CLIA/EMQN/NCCL certified medical laboratories equipped with advanced gene sequencing platforms. Services cover tumor management, hereditary disease screening, and infectious disease detection, serving hundreds of hospitals and research institutions across China with international operations in Hong Kong, Singapore, Japan, Europe, and North America.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Uni-medica Technology Co., Ltd
China · 3 relevant products
Cygnus Biosciences (Beijing)Co., Ltd.
China · 4 relevant products
STRATEC/Diatron
Germany · 1 relevant product
56 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →17 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 102 closest product alternatives
Shenzhen Uni-medica Technology Co., Ltd · China
A comprehensive genetic detection product called 'Bekang' that uses proprietary All-in-One ultra-high coverage PCR amplicon capture technology combined with next-generation sequencing to detect over 165 preventable genetic and metabolic diseases in newborns. It enables early detection, early diagnosis, and early treatment to reduce disease burden in infants.
Cygnus Biosciences (Beijing)Co., Ltd. · China
This product detects hereditary hypercholesterolemia risk-related genes including LDLR, APOB, PCSK9, LDLRAP1, ABCG5, and ABCG8, and simultaneously screens for drug-related genes SLCO1B1 and APOE to support clinical diagnosis and assessment.
Shenzhen Uni-medica Technology Co., Ltd · China
Next-generation sequencing-based screening for over 165 preventable genetic and metabolic diseases in newborns. Enables early detection, diagnosis, and treatment to reduce disease impact using patented All-in-One PCR amplicon capture technology.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products